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Microtubulesmany viruses exploit the host cell cytoskeleton to ensure intracellular transport,
assembly or egress. For Crimean-Congo hemorrhagic fever virus (CCHFV), the causative agent of a severe
hemorrhagic disease, virus–host interactions are poorly investigated. In this study we demonstrated that
drug-induced suppression of microtubule dynamics and especially microtubule disassembly, impaired
CCHFV biogenesis. Our results showed that intact microtubules were required early during virus
internalization, and late, during virus assembly and egress. Furthermore, disruption of microtubules resulted
in reduced levels of viral RNA while preservation of microtubule dynamics was most important during viral
egress. Finally, although CCHFV proteins were redistributed in drug-treated cells, the glycoprotein remained
associated with the Golgi apparatus, the organelle of virus budding. Taken together, our results suggest that
manipulation of microtubules affects CCHFV entry, replication, assembly and egress.
© 2008 Elsevier Inc. All rights reserved.IntroductionCrimean-Congo hemorrhagic fever virus (CCHFV) is the causative
agent of a serious human infection and has a reported case fatality
ranging between 3 and 30% (Ergonul, 2006; Whitehouse, 2004). The
virus belongs to the Nairovirus genus, family Bunyaviridae, and
circulates in nature in an enzootic tick–vertebrate–tick cycle (Schmal-
john and Nichol, 2007). Infected animals are usually asymptomatic
while in humans, the disease is manifested by symptoms such as fever,
prostration and hemorrhage (Swanepoel et al., 1987).
To date, CCHFV has been isolated from more than 30 different tick
species throughout the world with Hyalomma ticks as the principal
vector (Schmaljohn and Nichol, 2007). Recently, tick-borne diseases
has attracted focus since prevailing climate changes has been shown
to facilitate reproduction of tick populations and consequently
increase the incidence of tick-borne infections (Gubler et al., 2001).
Dissemination of CCHFV can also occur via birds that are refractory to
CCHFV infection but may carry the infected ticks over long distances
(Zeller et al., 1994). The molecular mechanism underlying CCHFV
pathogenesis, entry route and intracellular trafﬁcking are currently
poorly understood and research is further hampered by the require-ious Disease Control, S-171 82
n), cecilia.johansson@smi.ki.se
li.mirazimi@smi.ki.se
l rights reserved.ment of specialized laboratories, limited clinical facilities and the lack
of animal models.
Numerous studies have demonstrated the frequent employment of
host cell cytoskeleton in viral trafﬁcking, assembly or exit (Dohner and
Sodeik, 2005; Jouvenet et al., 2004; Lakadamyali et al., 2003;
McDonald et al., 2002; Newsome et al., 2004; Pelkmans et al., 2001;
Rietdorf et al., 2001; Sodeik et al., 1997; Suomalainen et al., 1999;
Yonezawa et al., 2005). The actin ﬁlaments are primarily found
directly beneath the plasma membrane while microtubules are
present throughout the cell. Therefore, for viruses that fuse with the
plasma membrane (HIV, herpes simplex virus), the dense actin cortex
provides a barrier during viral entry (Luby-Phelps, 2000). Most viruses
however, enter their host cells via the endocytic route and bypass the
actin barrier by traversing inside vesicles. Subsequent intracellular
transport occurs either by the direct interaction of the virus with
tubulins or via the endogenous endocytic pathway (Dohner and
Sodeik, 2005; Smith and Enquist, 2002). While the use of micro-
tubules in intracellular trafﬁcking is well characterized, less is known
about the role of microtubules in viral transcription and replication.
There are however a few studies demonstrating a role for both actin
ﬁlaments and microtubules in successful viral RNA expression (De et
al., 1993; Gupta et al., 1998; Kuhn et al., 2005; Mallardo et al., 2001;
Naghavi et al., 2007). Finally, to complete the viral life cycle, several
viruses interfere with actin ﬁlaments or microtubules before exit
occurs via exocytosis or cell lysis (Igakura et al., 2003; Jouvenet et al.,
2004; Jouvenet and Wileman, 2005; Ploubidou et al., 2000; Simpson-
Holley et al., 2002; Smith and Helenius, 2004; Smith and Enquist,
2002).
Fig. 1.Microtubule depolymerization and stabilization in response to NOC and PAC, respectively. Vero E6 cells were incubated in medium, 5 μMNOC or 20 μM PAC for 30 min before
ﬁxed and stained for α-tubulin. Nocodazole (NOC), paclitaxel (PAC).
Fig. 2. Production of CCHF progeny virus is reduced in response to microtubule
perturbations. Schematic illustration of drug treatments: dashed lines demonstrate the
start, duration and stop of NOC or PAC treatments (A). Vero E6 cells were pretreated
with NOC or PAC and infected in the presence of drugs for 24 h (−1h). Alternatively, cells
were ﬁrst infected and 6 h later treated with NOC or PAC (6 hpi). At the end of the
infection total progeny virus (extracellular and intracellular) was collected and titrated
for the assessment of progeny virus titers. Progeny virus in control cells corresponded to
1×107 FFU/ml. Presented data shows the average and standard deviations of three
separate experiments. Signiﬁcance is illustrated with pb0.001 (⁎⁎). Nocodazole (NOC),
paclitaxel (PAC).
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been demonstrated to occur in the cytoplasm (Schmaljohn and Nichol,
2007). Only a few publications has so far studied the employment of
host cell cytoskeleton in the life cycle of members within the Bunya-
viridae (Andersson et al., 2004; Banes and Coleman,1980; Ramanathan
et al., 2007; Ramanathan and Jonsson, 2008; Ravkov et al., 1998).
Recently, it was shown that an intact cell cytoskeleton is critical for
the efﬁcient replication of several Hantaviruses (Ramanathan et al.,
2007; Ramanathan and Jonsson, 2008). With regard to CCHFV, we
have previously shown that actin is important for the perinuclear
localization of CCHFV nucleocapsid protein (NP) and that actin and NP
co-immunoprecipitates (Andersson et al., 2004). In addition, progeny
virus titers are signiﬁcantly reduced when actin is disrupted
(Andersson et al., 2004). The role of microtubules however, has to
our knowledge not been investigated for CCHFV or any othermembers
of the Nairovirus genera.
In this study, we have examined the effects of two drugs that either
depolymerize or stabilize microtubules, in the life cycle of CCHFV. We
found that virus internalization was dependent on intact microtu-
bules, and when internalization was allowed in the absence of drugs,
primary transcription was equally efﬁcient in drug-treated as in
control cells. Depolymerization of microtubules was also inhibitory for
the expression of CCHFV RNA and consequently to progeny virus
production. Finally, efﬁcient virus assembly was dependent on intact
microtubules while CCHFV egress was dependent on both intact and
dynamic microtubules.
Results
Manipulation of microtubules is fast, reversible and does not affect
cellular viability
First, we investigated the kinetics ofmicrotubule depolymerization
and stabilization in response to nocodazole (NOC) or paclitaxel (PAC)
treatment, respectively. Staining against α-tubulins showed that
depolymerization and stabilization occurred within 30 min in
response to 5 μM NOC or 20 μM PAC, respectively (Fig. 1). In addition,
microtubule structure was restored within 30 min after NOC or PAC
washout (data not shown). Moreover, lactate dehydrogenase (LDH)-
assay showed that cell viability was not compromised despite
treatment of cells with NOC or PAC for as long as 24 h (data not
shown).
Perturbation of microtubules reduces CCHF progeny virus titers
To analyze the effects of NOC or PAC on total progeny virus
production, cells were treated with NOC or PAC before and throughout
infection for 24 h before cells and supernatants were collected and
titrated for progeny virus assessment (Fig. 2B, −1 h). Results showed a
signiﬁcant (pb0.001) decrease in progeny virus titers for both NOC
and PAC treated cells. Alternatively, cells were ﬁrst infected and
treated with NOC or PAC six to 24 h after infection (Fig. 2B, 6 hpi).Again, progeny virus titers were signiﬁcantly (pb0.001) lower in NOC
and PAC treated cells compared to control. Moreover, we found that
progeny virus titers were signiﬁcantly (pb0.001) lower in samples
treated with NOC or PAC before and throughout infection (−1h)
compared to cells that were treated 6 h after infection (6 hpi). These
data suggest an important role of microtubules in the life cycle of
CCHFV. Moreover, our results also suggest that part of themicrotubule
mediated inhibition occurs during the ﬁrst 6 h of infection.
CCHFV infection begins with positive sense RNA synthesis
Observing that microtubule integrity is important in CCHFV
biogenesis, we were interested to see in what step/s of the viral life
cycle microtubules were necessary. Because there is to date little
known about the kinetics of CCHFV RNA expression and synthesis, we
Fig. 3. CCHFVRNA synthesis over time. Vero E6 cells were infectedwith CCHFV for one, six
or 16 h. At the end of each incubation period cells were harvested, RNA was puriﬁed and
analyzed. Positive (messenger (m)/complementary (c)) and negative (viral (v)) CCHFV RNA
was quantiﬁed relative to bound non-replicating input virus that was set to 1. Data
represent the averages and standard errors of experiments performed in triplicates.
Fig. 4. CCHFV internalization requires intact microtubules. To determine CCHFV binding to
cells in response todrugs, cellswerepretreatedwithNOCorPAC followedbyvirusadsorption
for 1 h at 4 °C before cells were harvested (A). Total RNAwas puriﬁed and quantiﬁed relative
to control. To assess internalization, cells were pretreated similar to the binding assay above
before CCHFV internalization was allowed to proceed for 1 h at 37 °C (B). At the end of the
incubation period, cells were rinsed in low pH buffer to inactivate non-internalized virus
particles. Efﬁcient internalization was determined 24 h later by analyzing viral protein (NP)
expression. Presented data shows the average and standard deviations of three separate
experiments (a). Nocodazole (NOC), paclitaxel (PAC), nucleocapsid protein (NP).
Fig. 5.Microtubule integrity is not important for CCHFV primary transcription. Schematic
illustration of drug treatments: dashed lines demonstrate the start, duration and stop of
NOC or PAC treatments (A). Vero E6 cells were NOC or PAC treated before and during
infection for 6 h before cells were harvested, and total RNA was puriﬁed and quantiﬁed
(B, −1h). Alternatively, cells were drug treated 1 hpi and maintained in the presence of
drugs for 6 h before cells were harvested and total RNAwas quantiﬁed (C). Results show
the average and standard deviations of three separate experiments. Signiﬁcance is
illustrated with pb0.05 (⁎) or pb0.001 (⁎⁎). Nocodazole (NOC), paclitaxel (PAC).
315M. Simon et al. / Virology 385 (2009) 313–322investigated CCHFV RNA expression over time ﬁrst. Vero E6 cells were
infected and maintained for one, six or 16 h before cells were
harvested and CCHFV RNA expression was analyzed (Fig. 3). The
increase in RNA levels over time was determined relative to bound,
non-replicating virus. We found that during the ﬁrst 6 h of infection
CCHFV RNA expression increased and comprised mainly of positive
sense RNA (mRNA and possibly complementary RNA (cRNA)). In
contrast, negative sense RNA (vRNA) remained constant within this
time period. Since vRNA levels increased by 16 h post infection (hpi), it
seems that initiation of replication and therefore vRNA synthesis
occurred sometimes between six and 16 hpi.
Microtubule depolymerization impair CCHFV internalization
Because drug treatment before and during the ﬁrst 6 h of infection
impaired CCHFV biogenesis to a greater extent (Fig. 2), we performed a
number of experiments to investigate the role of microtubules in early
CCHFV infection speciﬁcally.
To investigate binding of CCHFV to Vero E6 cells, cells were
pretreated with NOC or PAC before virus was adsorbed to cells for 1 h
at 4 °C (Fig. 4A). Thereafter, cells were rinsed and harvested before
RNA was puriﬁed and quantiﬁed. Results showed that CCHFV RNA
levels were similar in all three, control, NOC and PAC treated cells,
suggesting that binding of CCHFV to its host cells was not impaired by
depolymerization or stabilization of microtubules.
To determine internalization in the presence of NOC or PAC, cells
were pretreated with the drugs and viral entry was allowed to occur
for 1 h at 37 °C (Fig. 4B). At the end of the incubation, cells were rinsed
in low pH buffer to inactivate non-internalized virions. Successful
infectionwas assayed 24 h later by western blot. Our results showed a
clear reduction in CCHFV nucleocapsid protein (NP) levels in NOC but
not PAC treated cells, suggesting that intact microtubules were
required in the internalization of CCHFV.
Microtubule perturbation does not interfere with primary transcription
Since internalization was affected by microtubule depolymeriza-
tion (Fig. 4B), wewere not surprised to see that RNA levels, quantiﬁed
6 hpi, were signiﬁcantly (pb0.001) lower in cells where NOC had
been added before infection (−1h) and maintained until harvest
(Fig. 5B). Surprisingly, we also observed a signiﬁcant (pb0.05) de-
crease in RNA levels in response to PAC treatment (Fig. 5B), sug-
gesting that some dynamic property of microtubules need to bemaintained in the early events of CCHFV infection. However, if CCHFV
internalization occurred in the absence of drugs, with drugs present
one to 6 hpi, CCHFV RNA expressionwas similar to control in NOC and
316 M. Simon et al. / Virology 385 (2009) 313–322PAC treated cells. These results suggest that microtubule integrity
and especially intact microtubules are important for CCHFV early
events. Moreover, our results also indicate that following the ﬁrst
hour after infection, CCHFV transcription is not dependent on main-
tained microtubule integrity.
Prolonged depolymerization of microtubules reduces CCHF progeny virus
and RNA levels
To address the effects of perturbed microtubules on CCHFV re-
plication, Vero E6 cells were treated with NOC or PAC one to 16 hpi
before cells were harvested (Figs. 6A–C). Drugs were added 1 hpi to
elude the negative effects of microtubule manipulation early in
infection (Fig. 4B) and 16-hour infections were chosen for harvest in
order to minimize contribution of more than one round of CCHFV
replication cycle. We found that drug treatment one to 16 hpi
decreased intracellular progeny virus and CCHFV RNA levels in
depolymerized but not stabilized cells (Fig. 6B). NOC treatment
resulted in a signiﬁcant (pb0.001) reduction of cell-associated
progeny virus while virus titers from PAC treated cells were similar
to control (Fig. 6B). Consistent with these results, quantiﬁcation of
CCHFV RNA revealed an approximately two-fold and signiﬁcant
(pb0.05) decrease in NOC but not PAC treated cells (Fig. 6C). Instead,
RNA levels were signiﬁcantly higher (pb0.05) in PAC treated cells
compared to control (Fig. 6C). To investigate whether the increase in
RNA levels were in response to PAC treatment and microtubule
stabilization speciﬁcally, cells were ﬁrst PAC treated similar to 6A and
B. Sixteen hpi PAC was rinsed away and cells were maintained for one
or 2 h in the absence of the drug before cells were harvested and RNA
was analyzed (Fig. 6D). Our results showed that CCHFV RNA levels
decreased with time to drug washout, suggesting that microtubule
stabilization enhanced RNA synthesis. Taken together, our resultsFig. 6. Depolymerization of microtubules decreases CCHFV RNA and progeny virus levels. Sch
stop of NOC or PAC treatments (A). Vero E6 cells were drug treated one to 16 hpi before c
harvested for the assessment of CCHFV total RNA synthesis (C). To investigate the role of PAC
rinsed andmaintained for one or 2 h in the absence of PAC before cells were harvested and RN
show the average and standard deviations of three separate experiments. Signiﬁcance is illindicate an important role for intact microtubules but not their
dynamic turnover in the replication process of CCHFV.
Microtubule depolymerization and stabilization alter the intracellular
distribution of CCHFV nucleocapsid protein and the glycoprotein GN
To study the intracellular distribution of CCHFV NP and the
glycoprotein GN in response to microtubule depolymerization and
stabilization, Vero E6 cells were treated with NOC or PAC and 24 hpi
cells were ﬁxed and stained for α−tubulins and NP or GN. In control
cells, NP localized to a number of sites close to the cell nucleus while
GN was mainly seen as a single perinuclear staining (Fig. 7A, left
panel). When microtubules were depolymerized with NOC, NP
redistributed to peripheral sites and partly maintained its perinuclear
staining while GN was completely dispersed within these cells (Fig 7A,
middle panel). In response to PAC, NP staining was similar to control
while GN dislocated from perinuclear to more peripheral, yet
concentrated sites within cells (Fig. 7A, right panel).
Since CCHFV assembly takes place in the Golgi apparatus
(Schmaljohn and Nichol, 2007), perturbation of Golgi structure or
function could result in poor assembly and reduced progeny virus
titers. Therefore, we investigated the drug-mediated effects on the
Golgi apparatus and the redistribution of CCHFV proteins by
performing colocalization analysis of CCHFV NP and GN with GM130
(cis-Golgi marker) (Fig. 7B). In control cells we found that NP localized
close to GM130 but without any detectable colocalization (Fig. 7B,
upper left panel). In contrast, we observed a distinct association
between GN and GM130 (Fig. 7B, lower left panel). Consistent with
previous results, Golgi was completely fragmented in response to NOC
(Fig. 7B, middle panel) while PAC treatment displaced Golgi from
perinuclear to peripheral sites within cells (Fig. 7B, right panel).
Despite Golgi fragmentation and displacement, association of GN withematic illustration of drug treatments: dashed lines demonstrate the start, duration and
ell-associated progeny virus was harvested and titrated (B). In parallel, cells were also
on total RNA synthesis, cells were ﬁrst drug treated one to 16 hpi. Thereafter cells were
Awas analyzed (D). Progeny virus in control cells corresponded to 1x105 FFU/ml. Results
ustrated with pb0.05 (⁎) or pb0.001 (⁎⁎). Nocodazole (NOC), paclitaxel (PAC).
Fig. 7. Pertubation of microtubules redistributes CCHFV proteins. Intracellular localization of CCHFV nucleocapsid protein (NP) and the glycoprotein GN was investigated in response
to NOC or PAC treatment. Vero E6 cells were infected and treated with NOC or PAC between six and 24 hpi before cells were ﬁxed and stained against NP, GN andα-tubulins (A) or NP,
GN and GM130 (a cis-Golgi marker) (B). Pictures were analyzed by confocal microscopy and representative images are shown for each drug and control treatments. Association of GN
with GM130 is demonstrated in the insets, highlighted in white. Nocodazole (NOC), paclitaxel (PAC).
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cells, NP showed little or no association with GM130 regardless of
drug treatment (Fig. 6B, upper panel). These data show that although
Golgi was fragmented or displaced in response to drug treatments,
association between GN and GM130 was largely maintained. This
suggests a partly sustained pathway of CCHFV biosynthesis through
the Golgi apparatus, a prerequisite for virus assembly and maturation.
Microtubule depolymerization or stabilization inhibits CCHFV egress
To investigate the engagement of microtubules in CCHFV egress,
Vero E6 cells were rinsed free of existing progeny virus at 24 hpi and
treated with NOC or PAC for 1 h (Fig. 8B). At the end of drug treatment,
extracellular progeny virus was collected and titrated. Results showed
that progeny virus titers decreased signiﬁcantly (pb0.001) for NOC
and PAC treated cells compared to control (Fig. 8B). To assess the
effects of drug reversion on extracellular progeny virus, the drug
treated cells were rinsed free of NOC or PAC and maintained for an
additional hour (Fig. 8B). As a consequence of regained microtubule
function, harvested progeny virus titers were restored and did not
differ signiﬁcantly from control (Fig. 8B). Because poor virus release
could be due to poor intracellular virus assembly, we investigated thecell-associated progeny virus levels. Cells were treated as above and
intracellular progeny virus was collected 1 h after drug treatment and
1 h after drug washout (Fig. 8C). We observed a signiﬁcant decrease in
progeny virus levels in response to NOC and a signiﬁcant increase in
progeny virus levels in response to PAC, suggesting that NOC impairs
virus assembly while PAC causes intracellular virus accumulation. To
determine the net effect of progeny virus formation, we summed the
intracellular and extracellular progeny viruses in each mock or drug
treated samples. In NOC treated cells progeny virus levels remained
signiﬁcantly (pb0.05) lower, suggesting that there was less progeny
virus formation overall (data not shown). In agreement with previous
results (Fig. 6B), total progeny virus titers in PAC treated cells were
similar to control levels (data not shown) and suggest that stabilized
microtubules mainly impair CCHFV egress. Taken together, our results
suggest that microtubules are engaged in CCHFV egress and when
microtubules are manipulated, viral egress is impeded. Moreover,
intact microtubules are also important for efﬁcient virus assembly.
Discussion
In this study we have investigated the role of microtubules in the
replication cycle of CCHFV.We found that internalizationwas dependent
Fig. 8. Perturbation of microtubules inhibits CCHFV egress. Schematic illustration of drug treatments: dashed lines demonstrate the start, duration and stop of NOC or PAC treatments
(A). Vero E6 cells were infected and treatedwith NOC or PAC between 25 and 26 hpi before extracellular progeny virus was collected (B). To assess reversion of drugs, cells were rinsed
free of drugs and maintained for 1 h before supernatants were harvested and titrated (B, washout (WO)). In parallel, progeny virus was also harvested from the intracellular
compartment (C). Presented data shows the average and standard deviations of three separate experiments. Signiﬁcance is illustrated with pb0.001 (⁎⁎). Nocodazole (NOC),
paclitaxel (PAC).
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of microtubule integrity. In response to depolymerization of micro-
tubules (DM), CCHFV RNA and progeny virus levels decreased while
stabilization of microtubules (SM) and DM impaired viral egress. Thus,
the data presented here reveal some new roles of microtubules in the
replication cycle of viruses that do not replicate in the nucleus.
Although the entry mechanism of CCHFV is not known, Hantaan
virus, (genus Hantavirus, family Bunyaviridae) has been shown to use
receptor-dependent clathrin-mediated endocytosis (Gavrilovskaya et
al., 1998; Jin et al., 2002). The entry mechanism of CCHFV has not been
addressed in this study; nonetheless, we show that binding is
independent of microtubules. Indeed, these ﬁndings are in line with
previous reports which demonstrate that microtubules are dispen-
sable for viral binding to the host cell (Chu and Ng, 2004; Dohner et al.,
2002; Funk et al., 2004; Lakadamyali et al., 2003; Suikkanen et al.,
2003) (Fig. 3). Once inside the cell, CCHFV needs to be transported to
the appropriate target sites before transcription and replication can be
initiated.
In this study we demonstrated that DM resulted in reduced CCHFV
early RNA synthesis (Fig. 5B). Closer analysis revealed that intact
microtubules were required already at the level of virus internalization
(Fig. 4B). The fact that SM reduced CCHFV early RNA synthesis (Fig. 5B)
without the expected reduction in virus internalization per se (Fig. 4B)
suggests thatmicrotubulesmaybeengaged inpost-internalization steps
as well. We therefore hypothesize that the ﬁrst hour following CCHFV
infection reﬂects the timeneeded for CCHFV to become internalized and
move along microtubules to reach the site of viral transcription.
In this study we have also showed, for the ﬁrst time, that early
infection (up to 6 hpi) consisted of positive sense RNA (m/cRNA)
synthesis while no increase could be detected in genomic, negative
RNA (vRNA) (Fig. 3). Consequently, early CCHFV infection most likelyrepresents viral transcription. Our results also indicate that sub-
sequent to early events following the ﬁrst hour post infection, CCHFV
transcription occurs equally efﬁcient in cells with DM, SM and
control. Viruses interfering with microtubule dynamics as well as the
use of microtubules in the early steps of a virus life cycle is not
unique and have been demonstrated for several viruses, including
other members of the Bunyaviridae (Dohner and Sodeik, 2005; Elliott
and O'Hare, 1998; Jouvenet et al., 2004; Ramanathan and Jonsson,
2008; Ruthel et al., 2005; Smith and Helenius, 2004). In contrast, less
is know about the involvement of microtubules in viral replication. In
this study we found that CCHFV RNA and progeny virus levels were
reduced in response to DM but not to SM when cells were analyzed
16 hpi (Figs. 6B and C). Because primary viral transcription was
unaffected (Fig. 5C), we hypothesize that drug treatment one to
16 hpi affects CCHFV replication rather than transcription. The role of
intact microtubules in CCHFV RNA synthesis, however, was not
critical since we only observed a two-fold reduction in RNA levels
when cells were analyzed 16 hpi (Fig. 6C). This also suggests that
CCHFV may employ alternate cellular structures during replication. In
line with this, most recent publications show that New and Old
World hantaviruses are impaired in RNA synthesis when actin
ﬁlaments or microtubules are disrupted (Ramanathan et al., 2007;
Ramanathan and Jonsson, 2008). Furthermore, a possible and indirect
role of microtubules was demonstrated in hantavirus replication. It
was shown that the viral nucleocapsid protein (NP) translocated
along microtubules, and when microtubules were disrupted NP
became dispersed and resulted in decreased viral RNA levels
(Ramanathan et al., 2007; Ramanathan and Jonsson, 2008). Also,
the architecture and function of viral factories in Bunyamwera virus
(family Bunyaviridae, genus Orthobunyavirus) assembly and matura-
tion were shown to require intact actin ﬁlaments (Fontana et al.,
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biogenesis and that CCHFV NP, similar to hantavirus Black Creek
Canal virus NP, co-immunoprecipitates with actin (Andersson et al.,
2004 data; Ravkov et al., 1998). The results in this study indicate a
role of microtubules in the replication process of CCHFV; however,
whether actin ﬁlaments or microtubules have redundant functions or
interact directly with the viral replication complex remain to be
elucidated.
In contrast to DM, SM resulted in increased RNA synthesis (Fig. 6D).
Further investigation revealed that SM speciﬁcally enhanced RNA
synthesis, a phenomenon also demonstrated for vesicular stomatitis
virus in vitro (Moyer et al., 1986). Because we were unable to perform
CCHFV replication in vitro, we cannot say whether tubulin is pivotal in
CCHFV replication, nor whether tubulin per se enhances replication.
However, since SM results in bundles of microtubules rather than
increasing tubulin concentration, it is possible that these bundles
rather tether and sequester components necessary for virus
replication.
CCHFV glycoproteins are synthesized in the ER before they are
transported to the Golgi apparatus for posttranslational processing
(Bertolotti-Ciarlet et al., 2005). Subsequent maturation occurs by
budding in the cisternae of the Golgi apparatus by the interaction of
ribonucleoparticles and glycoproteins before virions are released
along the secretory pathway (Schmaljohn and Nichol, 2007).
Considering the importance of Golgi in CCHFV biogenesis, disruption
of Golgi structure or function may be detrimental for CCHFV assembly
and maturation (Hoshino et al., 1997; Sandoval et al., 1984; Thyberg
and Moskalewski, 1985). Since fragmented Golgi stacks redistribute
close to ER exit sites and continue to promote transport of newly
synthesized proteins (Cole et al., 1996), it implies that translocation of
CCHFV glycoprotein GN, from ER to Golgi, should be sustained.
Accordingly, our results showed that GN was associated, albeit less
efﬁciently, with drug-induced fragmented or displaced Golgi elements
(Fig. 6B). Moreover, if translocation of viral glycoproteins and
subsequent assembly in Golgi is operational in cells with DM or SM,
the production of progeny virus titers should only be limited by the
availability of RNA. Indeed, the ratio of CCHFV RNA to progeny virus
was similar in drug treated and control cells, suggesting that
microtubules are not pivotal in CCHFV assembly.
In contrast to GN, CCHFV NP as well as hantavirus NP, do not
associate with Golgi (Andersson et al., 2004; Ramanathan et al., 2007;
Ramanathan and Jonsson, 2008). Instead hantavirus NP colocalize
with the ER–Golgi intermediate compartment (ERGIC) in a time
dependent manner by the employment of microtubules and micro-
tubule-associated motors (Ramanathan et al., 2007; Ramanathan and
Jonsson, 2008). ERGIC is an independent structure separated from the
ER and the Golgi complex and has been proposed to participate in the
biogenesis of several members of the Bunyaviridae (Jantti et al., 1997;
Matsuoka et al., 1991; Novoa et al., 2005; Ramanathan et al., 2007;
Ramanathan and Jonsson, 2008; Salanueva et al., 2003). In terms
of viral assembly and maturation, tubular shaped bunyavirus facto-
ries were demonstrated to build up around the Golgi complex and
were shown to harbour all the necessary components for viral
replication and assembly (Fontana et al., 2008). Whether CCHFV NP is
transported along microtubules to ERGIC and whether tubular virus
factories are part of CCHFV assembly and maturation is currently not
known.
Because the endogenous secretory pathway from Golgi to the
plasma membrane occurs along microtubules (Luini et al., 2008), it
seems reasonable that perturbation of microtubules also impede viral
egress. Consequently, we observed that both DM and SM affected
CCHFV egress and resulted in a signiﬁcant reduction of extracellular
progeny virus levels (Fig. 8). In cells with DM, we also found that virus
assembly was affected, suggesting that microtubules are involved in
this process. In contrast, in response to SM, progeny viruses
accumulated intracellularly. Thus, it seems that microtubules, directlyor indirectly, are involved in CCHFV assembly and egress, and when
microtubule dynamics are compromised, it mainly affects egress. In
addition to poor assembly, egress in the case of DM could simply be
that the tracks necessary for the outward transport of CCHFV are
absent. In the case of SM, the bundles of stabilized microtubules could
either provide a static barrier or perhaps interfere with the
recruitment of necessary structures needed to carry on with viral
egress.
In summary, our investigations on the role of microtubules in
CCHFV biogenesis have revealed that there are both microtubule
dependent and microtubule independent steps in the viral life cycle.
We found that CCHFV binding and early transcriptionwasmicrotubule
independent while CCHFV internalization, replication and conse-
quently progeny virus production was impaired in cells with DM.
Finally, both DM and SM reduced the extracellular levels of CCHFV
with DM also interfering with virus assembly.
Presently, the mechanism underlying CCHFV pathogenesis stands
far from complete. The results presented here further our under-
standing of CCHFV virus–host interactions and provide additional
information about the replication process of CCHFV. Thus, more
detailed investigations in the future may provide adequate informa-
tion that will be of importance for the development of antiviral targets
needed to ﬁght this emerging virus.
Materials and methods
Cell line and virus
CCHFV strain IbAr 10200, originally isolated in Nigeria in 1970
(Andersson et al., 2004; Flick et al., 2003) was used throughout the
experiments. Virus stock and virus titers were produced and
determined in Vero cells (monkey kidney cells, ATCC CRL-1587)
with indirect immunoﬂuorescent assay (IFA) against the CCHFV
nucleocapsid protein (NP) as described elsewhere (Andersson et al.,
2004). For CCHFV infections, Vero E6 cells (ATCC CRL-1586) were
seeded in 24-well plates and infected for 1 h at 37 °C in serum free
Dulbecco's modiﬁed Eagle's minimal essential medium (DMEM,
Invitrogen Corporation, Carlsbad, CA) supplemented with 10 U/ml
penicillin, 10 μg/ml streptomycin and 2% Hepes (Invitrogen
products). Viral infectious dose corresponded to 1 multiplicity of
infection (moi) (2.5×105 focus forming units (FFU)/well). One hour
post infection (hpi), cell were rinsed and infection was maintained
at 37 °C in DMEM supplemented with penicillin, streptomycin and
Hepes as described above and 2% foetal calf serum (FCS,
Invitrogen). All infections were carried out in a Biosafety Level 4
laboratory.
Antibodies and drugs
Primary antibodies used in this study were polyclonal rabbit anti-
CCHFV NP (Andersson et al., 2004), polyclonal rabbit anti-CCHFV GN
(glycoprotein) (Simon et al., 2006), monoclonal mouse anti-GM130
(Golgi) antibody (BD Biosciences, Franklin Lakes, NJ) and amonoclonal
mouse anti-α tubulin antibody (Invitrogen). Secondary antibodies
used were anti-rabbit ﬂuorescein isothiocyanate (FITC)-conjugated
antibody (DAKO, Glostrup, Denmark), anti-rabbit Alexa Fluor 488 and
anti-mouse Alexa Fluor 594 antibodies (Molecular Probes, Invitrogen).
All antibodies were diluted in PBSwith 0.1% Triton-X100 and 0.2% BSA.
The commercial antibodies were used and diluted as recommended
by themanufacturer. Nocodazole (NOC, a microtubule depolymerizing
drug) (De Brabander et al., 1977) and paclitaxel (PAC, a microtubule
stabilizing drug) (De Brabander et al., 1981; Schiff and Horwitz, 1980)
(Sigma-Aldrich, Saint Louis, MO) stock solutions were prepared in
DMSO according to instructions provided by the manufacturer.
Further dilution to working stock, 5 μM for NOC and 20 μM for PAC,
was done in culture medium.
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Cells were harvested with TRIzol and mixed with chloroform
followed by a short spin to obtain the water phase with RNA. All
subsequent steps for RNA isolationwere performed with RNeasy Mini
Kit (Qiagen GmbH, Hilden, Germany). cDNA was obtained by reverse
transcription of puriﬁed RNA with random or gene speciﬁc primers
and Superscript III (Invitrogen). Random primers were used for the
assessment of total RNA while CCHFV S segment forward (5′-GCC-
ATGATGTATTTGCCTTTGA-3′) or reverse (5′-CCAGTGAGCCATGAG-
CATGT-3′) primers were used to separately determine CCHFV m/
cRNA and vRNA levels, respectively. Quantitative real-time PCR
analyses were performed in an ABI sequence detector 7900 (Applied
Biosystems, Foster City, CA) with 40 cycles (95 °C for 15 s and 60 °C for
1 min). For CCHFV real-time PCR, the same primers as above were
used. GAPDH was used as endogenous control (forward primer: 5′-
CAGCATCGCCCCACTTG-3′; reverse primer: 5′-GAAATCCCATCACCATC-
TTCCA-3′). Ampliﬁcation reactions were performed in triplicates in
MicroAmp 96 well plates containing 20 μl SYBR Green Master mix
(Applied Biosciences) with 100 nM of each forward and reverse
primer, and cDNA. Relative RNA levels were determined either by
CCHFV RNA from non-replicating virus (1 h at 4 °C) as reference or
RNA levels were calculated relative to control. Relative RNA levels
were calculated with ΔΔCt (User bulletin 2, Applied Biosystems,
http://www.appliedbiosystems.com) based on the Ct value for each
sample. Uninfected control was included in all assays and was always
negative for CCHFV RNA.
Determination of progeny virus titers
Harvested progeny virus was serially 10 fold diluted and then
titrated on Vero cells in 96-well plates. Twenty-four hours later, cells
were ﬁxed in 80% aceton for 15 min and air-dried before plates were
probed with anti-CCHFV NP antibody followed by secondary FITC-
conjugated antibody. Probing with primary and secondary antibodies
was done at 37 °C for 1 h each. Fluorescent foci were counted in a
ﬂuorescent microscope enabling calculation of progeny virus titers in
FFU/ml.
Immunoﬂuorescence assay
Vero E6 cells were grown on Lab-Tek II chamber slides (Nalge Nunc
International, Rochester, NY) and treated with 5 μMNOC or 20 μMPAC
for 30min at 37 °C. At the end of the incubation, slides were ﬁxed in 4%
paraformaldehyde for 10 min followed by incubation in ice-cold
methanol for 10 min before probed with anti-α-tubulin antibodies
followed by secondary Alexa Fluor 594 antibodies. Images were
captured with a Hamamatsu digital camera.
For confocal images, Vero E6 cells were drug treated 6 hpi and
maintained in the presence of drugs until 24 hpi. At the end of the
infection, slides were ﬁxed as described above and probed with
primary anti-α-tubulins or anti-GM130 (cis-Golgi) and anti-CCHFVNP
or anti-CCHFV GN antibodies followed by secondary Alexa Fluor 488
and Alexa Fluor 594 antibodies. Incubation with primary and
secondary antibodies was performed at 37 °C for 1 h each. DAPI (4′,
6′-diamidino-2-phenylindole) (Sigma-Aldrich, St. Louis, MO)was used
to visualize the cell nucleus. For confocal microscope analysis, images
were captured using a DAS microscope Leitz DM RB with a
Hamamatsu dual mode cooled charged coupled device camera
C4880 at 63× magniﬁcation.
Confocal analysis
Confocal microscope images were analyzed for the association of
CCHFV proteins (NP and GN) and GM130 using ImageJ (W. S. Rasband,
National Institutes of Health, Bethesda, Md., 1997–2004, http://rsb.info.nih.gov/ij/). Acquired images were analyzed as individual green
and red channels corresponding to CCHFV NP or GN staining and
GM130, respectively. Background was corrected using the background
subtraction function of ImageJ. Manders' overlap coefﬁcient was
generated using theManders' coefﬁcient plug-in (Manders et al.,1993)
that is included in the WCIF version of ImageJ (http://www.
uhnresearch.ca/facilites/wcif/imagej/), with regions of interest set for
the green channel.
CCHFV RNA synthesis over time
To determine CCHFV positive (m/c) and negative (v) sense RNA
synthesis in infected Vero E6 cells over time, cells were infected for
one, six or 16 h. At the end of each incubation period, cells were
harvested, and RNA was isolated, reverse transcribed and quantiﬁed
with real-time PCR, as described above.
Microtubule perturbation and CCHFV infection
First we investigated the kinetic of microtubule depolymerization
and stabilization in Vero E6 cells. For this, cells were incubated with
5 μMNOC or 20 μM PAC for 30 min at 37 °C, ﬁxed and then stained for
α-tubulins before cells were studied under the microscope. To assess
drug reversion, cells were ﬁrst drug treated for 1 h at 37 °C and then
rinsed free of drugs. Cells were maintained for an additional 30 min
before ﬁxed and stained for α-tubulins.
Next, Vero E6 cells were seeded and grown conﬂuent in 24-well
plates and treated with NOC or PAC for 1 h at 37 °C. CCHFV was then
allowed to adsorb and bind to the cells for 1 h at 4 °C in the presence of
the drugs. At the end of adsorption, unbound virus was removed by
washing and cells were harvested with TRIzol (Invitrogen). RNA was
isolated, reverse transcribed and quantiﬁed with real-time PCR, as
described above. To determine CCHFV internalization in the presence
of NOC and PAC, Vero E6 cells were pretreated with the drugs (1 h at
37 °C) followed by CCHFV adsorption for 1 h at 4 °C. Internalization
was then allowed by a temperature shift to 37 °C for 1 h before cells
were rinsed and washed in low pH buffer for 1 min at room
temperature to inactive non-internalized virus. Thereafter, cells were
rinsed and maintained until 24 hpi before cells were harvested and
subjected to Western blot analysis. (Shortly, cell lysates were resolved
in 10% Tris–glycine polyacrylamide gel and transferred onto a
nitrocellulose membrane. After blocking in non-fat dry-milk, mem-
branes were incubated with primary anti-NP and anti-calnexin
antibodies followed by secondary HRP-conjugated antibodies.)
To investigate the effect of microtubule perturbation in prolonged
NOC or PAC treatments, Vero E6 cells were sometimes pretreated
before infection or drug treated post infection. Detailed illustration of
the experiment set-ups are depicted in association to each ﬁgure. In
infections up to 6 h, only CCHFV RNA levels were determined since
neither protein expression or progeny virus could be detected at this
time point. For infections exceeding 6 h, RNA or progeny virus levels
were used to determine infection efﬁciency.
Finally, to determine the effect of NOC and PAC in CCHFV egress,
Vero E6 cells were drug treated 24 hpi and maintained for 1 h in
the presence of drugs before extra- and intracellular progeny virus
was collected. Thereafter, cells were rinsed free of drugs to allow
for drug reversion and infection was resumed for an additional
hour before extra- and intracellular progeny virus was collected and
titrated.
Determination of cell viability in response to drug treatment
Measurement of lactate dehydrogenase (LDH) leakage was used to
demonstrate potential cell membrane damage. To evaluate the
toxicity of NOC and PAC, Vero E6 cells were maintained for 24 h in
the presence of drugs before supernatants were harvested and
321M. Simon et al. / Virology 385 (2009) 313–322assayed for LDH according to instructions provided by the manufac-
turer (CytoTox 96 Non-Radioactive Cytotoxicity Assay, Promega
Corporation, Madison, WI).
Statistical analyses
Student's t-test was used for the calculation of signiﬁcant
differences between control and drug treated cells. A p-valueb0.05
was considered signiﬁcant.
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